Does enhanced genetic testing impact myeloma patients? | Santiago Thibaud, MD | #ASH24

Does enhanced genetic testing impact myeloma patients? | Santiago Thibaud, MD | #ASH24
Loss of CD38 and Resistance Patterns in Myeloma | Benjamin Diamond, MD | #ASH24
IVIG and Preventing Infections in Myeloma Patients on Teclistamab | Heloise Cheruvalath | #ASH24
CAR-T Efficacy for Myeloma Patients with Bispecific Exposure | Johannes Waldschmidt, MD | #ASH24
New Insights for Amyloidosis in Myeloma | Suzanne Lentzsch, MD | #ASH24
What are the precursor conditions of multiple myeloma?